About the Authors
- Gülin Güler-Gane
-
Affiliation Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, United Kingdom
- Sara Kidd
-
Affiliation Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, United Kingdom
- Sudharsan Sridharan
-
Affiliation Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, United Kingdom
- Tristan J. Vaughan
-
Affiliation Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, United Kingdom
- Trevor C. I. Wilkinson
-
Affiliation Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, United Kingdom
- Natalie J. Tigue
-
* E-mail: tiguen@medimmune.com
Affiliation Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Granta Park, Cambridge, United Kingdom
Competing Interests
All authors are employees of MedImmune Ltd (a member of the AstraZeneca Group) and had stock or stock options in AstraZeneca, the parent company of MedImmune. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: NT GG. Performed the experiments: GG SK NT. Analyzed the data: GG NT. Contributed reagents/materials/analysis tools: GG SK SS. Wrote the paper: NT GG SK SS TV TW.